(1)

Pursuant to Article 5(1) of Decision 2013/34/CFSP, the Council authorised the Political and Security Committee (PSC) to take the relevant decisions concerning the political control and strategic direction of EUTM Mali, including the decisions on the appointment of subsequent EU Mission Force Commanders.

(2)

On 26 June 2017, the PSC adopted Decision (CFSP) 2017/1176 (2), appointing Brigadier General Bart LAURENT as EU Mission Force Commander.

(3)

On 24 October 2017, Spain proposed the appointment of Brigadier General Enrique MILLÁN MARTÍNEZ to succeed Brigadier General Bart LAURENT as the EU Mission Force Commander of EUTM Mali as from 31 January 2018.

(4)

On 5 December 2017, the EU Military Committee supported that recommendation.

(5)

A decision on the appointment of Brigadier General Enrique MILLÁN MARTÍNEZ should therefore be taken. Decision (CFSP) 2017/1176 should be repealed.

(6)

In accordance with Article 5 of Protocol No 22 on the position of Denmark, annexed to the Treaty on European Union and to the Treaty on the Functioning of the European Union, Denmark does not participate in the elaboration and the implementation of decisions and actions of the Union which have defence implications. Consequently, Denmark is not participating in the adoption of this Decision and is neither bound by it nor subject to its application,

(1)

Directive 92/119/EEC sets out the general Union control measures to be applied in the event of an outbreak of, inter alia, swine vesicular disease. Point 6 of Annex II to Directive 92/119/EEC indicates the European Union reference laboratory for swine vesicular disease which has been designated in order to carry out the functions and duties set out in Annex III thereto.

(2)

Directive 2003/85/EC sets out minimum control measures to be applied in the event of an outbreak of foot-and-mouth disease. Directive 2003/85/EC provides, inter alia, that a European Union reference laboratory for foot-and-mouth disease is to be designated in order to carry out the functions and duties set out in Annex XVI thereto. Subsequently, Commission Implementing Decision 2012/767/EU (3) designated the European Union reference laboratory for foot-and-mouth disease.

(3)

As a consequence of the United Kingdom's notification in accordance with Article 50 of the Treaty on European Union, the laboratory indicated in Annex II to Directive 92/119/EEC as the European Union reference laboratory for swine vesicular disease and subsequently designated by Implementing Decision 2012/767/EU as the European Union reference laboratory for foot-and-mouth disease will have to discontinue its functions as European Union reference laboratories for those two diseases.

(4)

The Commission, in close collaboration with the Member States, has carried out a call for selection and designation of the European Union Reference Laboratory for Foot-and-Mouth Disease, taking into account the criteria of the technical and scientific competence of the laboratory and its staff expertise.

(5)

Following completion of the selection procedure, the successful laboratory was the consortium ANSES & CODA-CERVA set up by the Laboratory for Animal Health of the Agency for Food, Environmental and Occupational Health and Safety (ANSES), Maisons-Alfort, France, and the Veterinary and Agrochemical Research Centre (CODA-CERVA), Uccle, Belgium.

(6)

In order to avoid any disruption of activities of the European Union reference laboratory for foot-and-mouth disease and to allow the newly designated European Union reference laboratory sufficient time to be fully operational, it is appropriate that the measures provided for in this Decision apply as from 1 January 2019.

(7)

In its Scientific Opinion on Swine Vesicular Disease and Vesicular Stomatitis (4), the European Food Safety Authority concluded that swine vesicular disease has no longer an epidemic potential and can be rapidly diagnosed by laboratory testing. In addition, the epidemiological situation as regards swine vesicular disease in the European Union has improved significantly and the last cases were only detected through laboratory testing of samples from a small region in a single Member State. Since 2014, swine vesicular disease is no longer listed as notifiable disease by the World Organisation for Animal Health (OIE) (5).

(8)

Although Directives 92/119/EEC and 2003/85/EC will be repealed as of 21 April 2021 in accordance with Article 270 of Regulation (EU) 2016/429 of the European Parliament and of the Council (6), foot-and-mouth disease is listed in Article 5(1) of that Regulation, while swine vesicular disease is listed in Annex II thereto. In accordance with Article 275 of that Regulation, the list of diseases in Annex II shall be reviewed at the latest by 20 April 2019. For the above mentioned scientific and technical reasons, swine vesicular disease does not meet the criteria for listing set out in Article 5(3) of Regulation (EU) 2016/429.

(9)

Furthermore, swine vesicular disease and other vesicular diseases are included in certain functions and duties set out for the European Union reference laboratory for foot-and-mouth disease in Annex XVI to Directive 2003/85/EC, and in particular as regards the capacity of national reference laboratories and the European Union reference laboratory to carry out the differential diagnosis of foot-and-mouth disease. All these elements together allow discontinuing the designation of a European Union reference laboratory for swine vesicular disease.

(10)

The reference made to the laboratory indicated in Annex II to Directive 92/119/EEC should be deleted. Annex II to Directive 92/119/EEC should therefore be amended accordingly.

(11)

In the interest of clarity, Implementing Decision 2012/767/EU should be repealed with effect of 1 January 2019, the date on which the newly designated European Union reference laboratory for foot-and-mouth disease is to take up its function and duties.

(12)

The measures provided for in this Decision are in accordance with the opinion of the Standing Committee on Plants, Animals, Food and Feed,